HOLX Key Statistics, Chart & Performance
The current stock price of HOLX is 74.545 USD. In the past month the price decreased by -0.4%. In the past year, price increased by 1.84%.
HOLX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.19 | 218.54B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.29 | 202.34B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.44 | 141.85B | ||
| SYK | STRYKER CORP | 26.78 | 134.87B | ||
| BDX | BECTON DICKINSON AND CO | 13.55 | 55.76B | ||
| IDXX | IDEXX LABORATORIES INC | 53.88 | 54.26B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.35 | 49.74B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.01 | 37.66B | ||
| RMD | RESMED INC | 24.5 | 35.40B | ||
| DXCM | DEXCOM INC | 35.84 | 26.00B | ||
| PODD | INSULET CORP | 62.4 | 20.06B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.19 | 17.94B |
Related stock screener links
About HOLX
Company Profile
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Company Info
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752 US
CEO: STEPHEN P. MACMILLAN
Employees: 7070
Phone: 15082632900
HOLOGIC INC / HOLX FAQ
Can you describe the business of HOLOGIC INC?
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Can you provide the latest stock price for HOLOGIC INC?
The current stock price of HOLX is 74.545 USD. The price increased by 0.01% in the last trading session.
Does HOLOGIC INC pay dividends?
HOLX does not pay a dividend.
How is the ChartMill rating for HOLOGIC INC?
HOLX has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the GICS sector and industry of HOLX stock?
HOLOGIC INC (HOLX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is HOLOGIC INC worth?
HOLOGIC INC (HOLX) has a market capitalization of 16.62B USD. This makes HOLX a Large Cap stock.
What is the ownership structure of HOLOGIC INC (HOLX)?
You can find the ownership structure of HOLOGIC INC (HOLX) on the Ownership tab.
HOLX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to HOLX. When comparing the yearly performance of all stocks, HOLX turns out to be only a medium performer in the overall market: it outperformed 61.72% of all stocks.
HOLX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to HOLX. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
HOLX Financial Highlights
Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.27. The EPS increased by 4.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.8% | ||
| ROA | 6.28% | ||
| ROE | 11.21% | ||
| Debt/Equity | 0.5 |
HOLX Forecast & Estimates
25 analysts have analysed HOLX and the average price target is 76.86 USD. This implies a price increase of 3.11% is expected in the next year compared to the current price of 74.545.
For the next year, analysts expect an EPS growth of 8.74% and a revenue growth 5.02% for HOLX